Dr. Grace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Longwood Ave
Childrens Hospital Boston Karp 8
Boston, MA 02115Phone+1 617-355-6000- Is this information wrong?
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2003 - 2006
- The Warren Alpert Medical School of Brown UniversityClass of 2003
Certifications & Licensure
- MA State Medical License 2006 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP Start of enrollment: 2013 Aug 01
- Pyruvate Kinase Deficiency Natural History Study Start of enrollment: 2013 Dec 01
- A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency Start of enrollment: 2015 Jun 26
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsExome sequencing results in successful diagnosis and treatment of a severe congenital anemiaJessica Lacy, Jacob C. Ulirsch, Rachael F. Grace, Meghan C. Towne, John Hale
Cold Spring Harbor Molecular Case Studies. 2016-07-01 - 85 citationsSafety and efficacy of mitapivat in pyruvate kinase deficiencyRachael F. Grace, Christian Rose, D. Mark Layton, Frédéric Galactéros, Wilma Barcellini
The New England Journal of Medicine. 2019-09-04 - 606 citationsAmerican Society of Hematology 2019 guidelines for immune thrombocytopeniaCindy Neunert, Deirdra R. Terrell, Donald M. Arnold, George R. Buchanan, Douglas B. Cines
Blood Advances. 2019-12-10
Abstracts/Posters
- A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in ChildrenRachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Characterization of the Severe Phenotype of Pyruvate Kinase DeficiencyRachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Comorbidities and Complications in Adults with Pyruvate Kinase DeficiencyRachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- An Ongoing Global, Longitudinal, Observational Study of Patients with Pyruvate Kinase Deficiency: The PEAK Registry61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Special Education Session on ASH Clinical Practice Guidelines on Immune Thrombocytopenia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
- Mitapivat Produces Durable Hemoglobin Responses in Patients with Pyruvate Kinase DeficiencyDecember 11th, 2021
- More Than 110 Dana-Farber Affiliated Faculty Named as 2021 Top Doctors in Boston MagazineJanuary 5th, 2021
- Mitapivat Elicits Positive Response in Pyruvate Kinase DeficiencySeptember 4th, 2019
- Join now to see all
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Boston Children's HospitalBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: